title: Evaluation of a quality-of-life tool for cats with diabetes mellitus.
abstract: BACKGROUND
  Success in management of diabetes mellitus (DM) is defined as improvement of blood glucose concentrations and clinical signs. However, the psychological and social impact of DM and its daily treatment regimen on quality of life (QoL) of both animal and owner is uncertain.
  
  
  OBJECTIVE
  To design, validate, and apply a diabetic pet and owner-centered, individualized measure of impact of DM (DIAQoL-pet). ANIMALS/SUBJECTS: Two hundred and twenty-one owners of insulin-treated diabetic cats were recruited to complete the DIAQoL-pet.
  
  
  METHODS
  Discussions and pilot surveys with clinicians and owners of diabetic cats led to the design of 29 specific DM-associated QoL questions. Owners of diabetic cats completed the finalized survey. Each item was scored according to impact frequency and perceived importance. An item-weighted impact score (IWIS) for each item was calculated, as was an average-weighted impact score (AWIS) by averaging all IWISs. Principal component analysis and Cronbach's α calculation assessed the measure's reliability. Two overview questions measured overall QoL and diabetes-dependent QoL.
  
  
  RESULTS
  The DIAQoL-pet showed high reliability (Cronbach α 0.83). The AWIS was -1.76 ± 2.4 (mean ± SD). Areas reported as most negatively impacting QoL included: "boarding difficulties" (IWIS ± SD: -4.67 ± 5.3), "owner wanting more control" (-4.34 ± 4.7), "difficulties leaving cat with friends or family" (-4.21 ± 4.7), "worry" (-4.10 ± 3.9), "worry hypo" (-3.67 ± 3.5), "social life" (-3.48 ± 3.9), "costs" (-3.04 ± 3.8), and "work life" (-3.03 ± 3.7). Forty-one percent of owners believed their cat's life would be "a little better" without DM.
  
  
  CONCLUSIONS
  The DIAQoL-pet proved robust and identified specific areas most negatively impacting on diabetic cats and their owners' QoL. This tool warrants further investigation for use in clinical or research settings.
authors: Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, North Mymms, Hertfordshire, UK. sniessen@rvc.ac.uk
authors: S J M
authors: SJ
authors: Niessen
authors: S
authors: S
authors: Powney
authors: J
authors: J
authors: Guitian
authors: A P M
authors: AP
authors: Niessen
authors: P D
authors: PD
authors: Pion
authors: J A M
authors: JA
authors: Shaw
authors: D B
authors: DB
authors: Church
mesh_terms: D000818:Animals; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000662:veterinary*; D006305:Health Status Indicators; D001841:Human-Animal Bond; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D011788:Quality of Life / Q000523:psychology*; D011795:Surveys and Questionnaires
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin